fig1

Novel diagnosis and therapy for hepatoma targeting HBV-related carcinogenesis through alternative splicing of FIR (PUF60)/FIRΔexon2

Figure 1. Structures of small molecular weight chemicals that were interacted with His-tagged far upstream element-binding protein-interacting repressor (His-FIR) or His-FIRΔexon2 screened by natural product depository (NPDepo) (RIKEN, JPN). 3+: strong interaction; 2+: moderate interaction; 1+: weak interaction; IUPAC: International Union of Pure and Applied Chemistry

Hepatoma Research
ISSN 2454-2520 (Online) 2394-5079 (Print)

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/